According to Biolife Solutions 's latest financial reports the company's current EPS (TTM) is -$1.93. In 2022 the company made an earnings per share (EPS) of -$3.28 a decrease over its 2021 EPS that were of -$0.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.93 | -41.16% |
2022 | -$3.28 | 1555.58% |
2021 | -$0.20 | -383.03% |
2020 | $0.07000 | -117.07% |
2019 | -$0.41 | -327.78% |
2018 | $0.18 | -185.71% |
2017 | -$0.21 | -61.82% |
2016 | -$0.55 | 57.14% |
2015 | -$0.35 | 9.37% |
2014 | -$0.32 | 44.51% |
2013 | -$0.22 | -43.17% |
2012 | -$0.39 | -30.42% |
2011 | -$0.56 | -0% |
2010 | -$0.56 | -0% |
2009 | -$0.56 | -0% |
2008 | -$0.56 | -0% |
2007 | -$0.56 | -0% |
2006 | -$0.56 | -0% |
2005 | -$0.56 | -33.33% |
2004 | -$0.84 | -62.5% |
2003 | -$2.24 | -500% |
2002 | $0.56 | -110.81% |
2001 | -$5.18 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Celanese CE | $11.70 | -706.22% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | -$6.31 | 226.94% | ๐บ๐ธ USA |
Amyris AMRS | -$1.83 | -5.18% | ๐บ๐ธ USA |